Certainly, this is a preliminary study considering the roles of LINC01268 in AML, and the promotion of the LINC01268/miR-217/SOS1 axis in the progression of AML still needs to be further validated by animal experiments and clinical trials. The gene discussed is SOS1; the disease is acute myeloid leukemia.